InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: Timing101 post# 54853

Wednesday, 12/09/2020 6:24:30 PM

Wednesday, December 09, 2020 6:24:30 PM

Post# of 198603
Yes, thank you for that, and here's something to ADD to your post:

Clip from yesterday's article in CFO/CEO Magazine

The Enzolytics anti-HIV treatment is now being advanced through the certification stage to thereafter be made available for patient therapy.

"The Company is now combining this technology with recently acquired technology, created by BioClonetics Immunotherapeutics, for creating fully human anti-monoclonal antibodies for treating HIV. Using this technology, the Company has produced fully human anti-monoclonal antibodies that have been tested in 5 international labs where it neutralized over 95% of all strains of the HIV virus against which it was tested. Additional neutralizing antibodies are being produced.

The therapies of Enzolytics’ are two technologies produced by Enzolytics and BioClonetics, are expected to be synergistic.

Additionally, because the HIV virus and the Corona Virus have correlative structures and with our knowledge of how our monoclonal antibodies neutralize HIV, we are now developing monoclonal antibodies for treating the CoronaVirus."

In view of your post and this one, I would say things are shaping up nicely!

Cheers!

Be well and prosper...